N- (6- (4- butanoyl- 5- methyl- 1H- pyrazol- 1- yl)pyridazin- 3- yl)- 5- chloro- 1- (2- (4- methylpiperazin- 1- yl)- 2- oxoethyl)- 1H- indole- 3- carboxamide
a platelet aggregation inhibitor with P2Y12 antagonist activity; structure in first source
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Boldron, C:
1 article
(09/2014)
|
2. | Bonnet-Lignon, S:
1 article
(09/2014)
|
3. | Bono, F:
1 article
(09/2014)
|
4. | Delesque-Touchard, N:
1 article
(09/2014)
|
5. | Herbert, J M:
1 article
(09/2014)
|
6. | Lassalle, G:
1 article
(09/2014)
|
7. | Millet, L:
1 article
(09/2014)
|
8. | Pflieger, A M:
1 article
(09/2014)
|
9. | Salel, V:
1 article
(09/2014)
|
10. | Savi, P:
1 article
(09/2014)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures